Cargando…

A comprehensive overview on antibody-drug conjugates: from the conceptualization to cancer therapy

Antibody-Drug Conjugates (ADCs) represent an innovative class of potent anti-cancer compounds that are widely used in the treatment of hematologic malignancies and solid tumors. Unlike conventional chemotherapeutic drug-based therapies, that are mainly associated with modest specificity and therapeu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Riccardi, Federico, Dal Bo, Michele, Macor, Paolo, Toffoli, Giuseppe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10544916/ https://www.ncbi.nlm.nih.gov/pubmed/37790810 http://dx.doi.org/10.3389/fphar.2023.1274088

Ejemplares similares

Novel Nanotechnology Approaches to Overcome Drug Resistance in the Treatment of Hepatocellular Carcinoma: Glypican 3 as a Useful Target for Innovative Therapies
por: Mossenta, Monica, et al.
Publicado: (2022)

Nanoparticles-Based Oligonucleotides Delivery in Cancer: Role of Zebrafish as Animal Model
por: Bozzer, Sara, et al.
Publicado: (2021)

The Proteoglycan Glypican-1 as a Possible Candidate for Innovative Targeted Therapeutic Strategies for Pancreatic Ductal Adenocarcinoma
por: Busato, Davide, et al.
Publicado: (2022)

Nanocarriers as a Delivery Platform for Anticancer Treatment: Biological Limits and Perspectives in B-Cell Malignancies
por: Bozzer, Sara, et al.
Publicado: (2022)

Zebrafish: A Useful Animal Model for the Characterization of Drug-Loaded Polymeric NPs
por: Bozzer, Sara, et al.
Publicado: (2022)

A novel complement-fixing IgM antibody targeting GPC1 as a useful immunotherapeutic strategy for the treatment of pancreatic ductal adenocarcinoma
por: Busato, Davide, et al.
Publicado: (2023)

Biological Features of Nanoparticles: Protein Corona Formation and Interaction with the Immune System
por: Panico, Sonia, et al.
Publicado: (2022)

Surface antibody changes protein corona both in human and mouse serum but not final opsonization and elimination of targeted polymeric nanoparticles
por: Capolla, Sara, et al.
Publicado: (2023)

Book Review: Antibody-Drug Conjugates: Fundamentals, Drug Development, and Clinical Outcomes to Target Cancer
por: Dhakal, Dipesh, et al.
Publicado: (2017)

A review of recent advances on single use of antibody-drug conjugates or combination with tumor immunology therapy for gynecologic cancer
por: Wang, An-Jin, et al.
Publicado: (2022)

Incorporation of Hydrophilic Macrocycles Into Drug-Linker Reagents Produces Antibody-Drug Conjugates With Enhanced in vivo Performance
por: Evans, Nick, et al.
Publicado: (2022)

Chitosan-Based Biocompatible Copolymers for Thermoresponsive Drug Delivery Systems: On the Development of a Standardization System
por: Marsili, Lorenzo, et al.
Publicado: (2021)

The Dual Role of the Liver in Nanomedicine as an Actor in the Elimination of Nanostructures or a Therapeutic Target
por: Baboci, Lorena, et al.
Publicado: (2020)

Repeated Use of Prescription Drugs in Pediatrics: Comprehensive Overview Based on German Claims Data
por: Scholle, Oliver, et al.
Publicado: (2021)

Comprehensibility of a personalized medication overview compared to usual-care prescription drug labels
por: Schackmann, Laura, et al.
Publicado: (2022)

Research Trend of Publications Concerning Antibody-Drug Conjugate in Solid Cancer: A Bibliometric Study
por: Qi, Xiangjun, et al.
Publicado: (2022)

Do antibody–drug conjugates increase the risk of sepsis in cancer patients? A pharmacovigilance study
por: Xia, Shuang, et al.
Publicado: (2022)

An overview of antibody–drug conjugates in oncological practice
por: Theocharopoulos, Charalampos, et al.
Publicado: (2020)

A multifunctional drug consisting of tetracycline conjugated with odanacatib for efficient periodontitis therapy
por: Li, Dengke, et al.
Publicado: (2022)

Linker Design Impacts Antibody-Drug Conjugate Pharmacokinetics and Efficacy via Modulating the Stability and Payload Release Efficiency
por: Su, Dian, et al.
Publicado: (2021)

An Overview of Antibody Conjugated Polymeric Nanoparticles for Breast Cancer Therapy
por: Juan, Alberto, et al.
Publicado: (2020)

Dual-Responsive Core Crosslinking Glycopolymer-Drug Conjugates Nanoparticles for Precise Hepatocarcinoma Therapy
por: Wu, Jing, et al.
Publicado: (2018)

Antibody–Drug Conjugates for Cancer Therapy
por: Parslow, Adam C., et al.
Publicado: (2016)

Antibody–Drug Conjugates for Cancer Therapy
por: Hafeez, Umbreen, et al.
Publicado: (2020)

Predicting Response to Antibody Drug Conjugates: A Focus on Antigens’ Targetability
por: Ascione, Liliana, et al.
Publicado: (2023)

Thermoresponsive Chitosan-Grafted-Poly(N-vinylcaprolactam) Microgels via Ionotropic Gelation for Oncological Applications
por: Marsili, Lorenzo, et al.
Publicado: (2021)

Glutathione S-conjugates as prodrugs to target drug-resistant tumors
por: Ramsay, Emma E., et al.
Publicado: (2014)

An Overview of the Evidence and Mechanisms of Herb–Drug Interactions
por: Fasinu, Pius S., et al.
Publicado: (2012)

Novel potential pharmacological applications of dimethyl fumarate—an overview and update
por: Bresciani, Giorgia, et al.
Publicado: (2023)

An Overview of the Evidence and Mechanism of Drug–Herb Interactions Between Propolis and Pharmaceutical Drugs
por: Hossain, Sanowar, et al.
Publicado: (2022)

Role of Virus-Related Chronic Inflammation and Mechanisms of Cancer Immune-Suppression in Pathogenesis and Progression of Hepatocellular Carcinoma
por: Borgia, Melissa, et al.
Publicado: (2021)

Function of Epirubicin-Conjugated Polymeric Micelles in Sonodynamic Therapy
por: Takemae, Kazuhisa, et al.
Publicado: (2019)

A comprehensive overview of clinical research on dexmedetomidine in the past 2 decades: A bibliometric analysis
por: Kong, Hao, et al.
Publicado: (2023)

Overview and Analysis of the Cost of Drug Programs in Poland: Public Payer Expenditures and Coverage of Cancer and Non-Neoplastic Diseases Related Drug Therapies from 2015–2018 Years
por: Mela, Aneta, et al.
Publicado: (2020)

Germline and Somatic Pharmacogenomics to Refine Rectal Cancer Patients Selection for Neo-Adjuvant Chemoradiotherapy
por: De Mattia, Elena, et al.
Publicado: (2020)

An Overview of the Development and Preclinical Evaluation of Antibody–Drug Conjugates for Non-Oncological Applications
por: Pal, Lal Bahadur, et al.
Publicado: (2023)

Traditional Chinese medicine in treating ischemic stroke by modulating mitochondria: A comprehensive overview of experimental studies
por: Liu, Lu, et al.
Publicado: (2023)

Site-specific antibody drug conjugates for cancer therapy
por: Panowski, Siler, et al.
Publicado: (2013)

Potential of antibody–drug conjugates (ADCs) for cancer therapy
por: Marei, Hany E., et al.
Publicado: (2022)

Trends in the Development of Antibody-Drug Conjugates for Cancer Therapy
por: Song, Chi Hun, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0j62a0pi5mte9f0p11rhfj7mdr